NDC 25021-0651-02 10

Orphenadrine citrate 30 mg/mL 2 mL Vial 2024-07-16

Supplier Sagent Pharmaceuticals
Availability Status ASHP Shortage + QS Availability Issues (2024-07-16)
Status Description

QuicksortRx has identified an availability disruption across multiple channels, and ASHP has published an active drug shortage for this product. See their website for more information.

Quicksort Status Availability Issues Detected (2024-07-16)
ASHP Status ASHP Shortage Declared (2024-07-16)
QUMI Product Code wnzv038 (QuicksortRx Universal Medication Identifier)

NDC Package Count Supplier Description Status Updated
00641-6182-10
10 Hikma Pharmaceuticals USA Inc. Orphenadrine citrate 30 mg/mL 2 mL Vial ASHP Shortage + QS Availability Issues 2024-07-16
17478-0538-02
10 Akorn Orphenadrine citrate 30 mg/mL 2 mL Vial No Availability Issues Detected
70518-3823-00
10 REMEDYREPACK INC. Orphenadrine citrate 30 mg/mL 2 mL Vial No Availability Issues Detected

QUMI Codes

QUMI Code Route Strength Form NDC Count Description
5ja020w Oral 100 mg Extended Release Oral Tablet 53 12 HR orphenadrine citrate 100 mg Extended Release Oral Tablet
kjx4qd4 Injectable 60 mg Ampule 1 Orphenadrine citrate 30 mg/mL 2 mL Ampule

Previous Status Status Start Date Status End Date
ASHP Shortage + QS Availability Issues 2024-07-16 Current
No Availability Issues Detected 2024-07-16

RXCUI: 994541
Dosage Form: Vial
Dosage Route: INJECTABLE
Strength: 60
Measure: mg
ANDA: ANDA090585
Generic Description: ORPHENADRINE CITRATE
DEA: